Skip to content
Back to recalls
Drug FDA Class II Ongoing Mislabeling

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles Published May 13, 2026

Risk level

Class II

May cause a temporary or reversible health problem; slight chance of serious harm.

Severity score 50/100

What should you do?

  • Check whether you have this product, using the lot codes, UPCs, and dates listed below.
  • Do not eat, serve, or sell the affected product.
  • Return it to the place of purchase for a refund, or throw it away in a sealed bag so people and animals can’t get to it.
  • Contact Central Admixture Pharmacy Services, Inc (CAPS) Los Angeles or your place of purchase with questions, and see the source record below for full details.
Reason for recall

Incorrect Product Formulation: product did not contain insulin as listed in the label.

Affected products (1)

TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670

1 bag

Code info: Lot #: 11-4909703-0-1, Exp 12/28/2025

Affected areas

California

Timeline

  1. Initiated
    Dec 27, 2025
  2. Published
    May 13, 2026
Recall number
D-0524-2026
Agency
U.S. Food and Drug Administration
Country
US
Source data (openFDA JSON) About FDA enforcement reports

FDA records come from the openFDA drug enforcement-report dataset — the agency's full weekly enforcement list. Most entries are not issued as consumer press releases, so they won't appear on fda.gov/recalls or in a web search. The source record link above resolves this exact recall by its number.